Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis

被引:36
作者
Pickard, C
Mann, C
Sinnott, P
Boggild, M
Hawkins, C
Strange, RC
Hutchinson, IV
Ollier, WER
Donn, RP
机构
[1] Univ Manchester, ARC Epidemiol Res Unit, Manchester M13 9PT, Lancs, England
[2] St James Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England
[3] N Staffordshire Royal Infirm, Dept Neurol, Stoke On Trent, Staffs, England
[4] Royal London Hosp, Tissue Typing Lab, London E1 2AG, England
[5] Walton Ctr, Liverpool L9 1AE, Merseyside, England
[6] N Staffordshire Hosp, Ctr Cell & Mol Med, Stoke On Trent ST4 7QB, Staffs, England
[7] Univ Manchester, Sch Biol Sci, Dept Immunol, Manchester M13 9PT, Lancs, England
关键词
interleukin-10; multiple sclerosis; disease severity;
D O I
10.1016/S0165-5728(99)00146-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-10 (IL10) is an anti-inflammatory cytokine which may modulate disease expression in multiple sclerosis (MS). Three dimorphic polymorphisms within the IL10 promoter region at positions - 1082, - 819 and - 519 have previously been identified. The - 1082*A allele has been associated with low and the - 1082*G allele with high in vitro IL10 production. We have genotyped 185 Caucasian MS patients and 211 ethnically matched controls for each of these three dimorphisms. MS patients were stratified for severity of disease outcome. No associations were found for any IL10 promoter polymorphisms when the MS cases were compared with controls or with disease outcome with regards to disability. IL10 polymorphism does not appear to be associated with MS or to influence disease progression. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 14 条
  • [1] THE ADHESION MOLECULE AND CYTOKINE PROFILE OF MULTIPLE-SCLEROSIS LESIONS
    CANNELLA, B
    RAINE, CS
    [J]. ANNALS OF NEUROLOGY, 1995, 37 (04) : 424 - 435
  • [2] CORREALE J, 1995, J IMMUNOL, V154, P2959
  • [3] Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO
  • [4] 2-Y
  • [5] Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis
    He, B
    Xu, C
    Yang, B
    Landtblom, AM
    Fredrikson, S
    Hillert, J
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1998, 86 (01) : 13 - 19
  • [6] ISOLATION OF THE HUMAN INTERLEUKIN-10 PROMOTER - CHARACTERIZATION OF THE PROMOTER ACTIVITY IN BURKITTS-LYMPHOMA CELL-LINES
    KUBE, D
    PLATZER, C
    VONKNETHEN, A
    STRAUB, H
    BOHLEN, H
    HAFNER, M
    TESCH, H
    [J]. CYTOKINE, 1995, 7 (01) : 1 - 7
  • [7] STUDIES ON NATURAL-HISTORY OF MULTIPLE-SCLEROSIS .8. EARLY PROGNOSTIC FEATURES OF LATER COURSE OF ILLNESS
    KURTZKE, JF
    BEEBE, GW
    NAGLER, B
    KURLAND, LT
    AUTH, TL
    [J]. JOURNAL OF CHRONIC DISEASES, 1977, 30 (12): : 819 - 830
  • [8] KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
  • [9] Haplotype associated with low interleukin-10 production in patients with severe asthma
    Lim, S
    Crawley, E
    Woo, P
    Barnes, PJ
    [J]. LANCET, 1998, 352 (9122) : 113 - 113
  • [10] The pattern of production of cytokine mRNAs is markedly altered at the onset of multiple sclerosis
    Musette, P
    Benveniste, O
    Lim, A
    Bequet, D
    Kourilsky, P
    Dormont, D
    Gachelin, G
    [J]. RESEARCH IN IMMUNOLOGY, 1996, 147 (07): : 435 - 441